Alyeska Investment Group
SRGA

Alyeska Investment Group’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Alyeska Investment Group’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-70,000
Closed -$239K – 690
2022
Q2 		$239K Hold
70,000
– – ﹤0.01% 546
2022
Q1 		$639K Buy
+70,000
New +$1.06M 0.01% 536

Other funds holding SRGA

AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alyeska Investment Group's SRGA Position: Q3 2022 in Review

Alyeska Investment Group sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2022, closing a stake of 70,000 shares — an estimated $239K sold.

Alyeska Investment Group first reported a position in SRGA in Q1 2022 and held it in 2 quarters. The position peaked at $639K in Q1 2022. 36 funds tracked by Wall St. Rank hold SRGA as of Q3 2022.

  • Alyeska Investment Group reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 70,000 Surgalign Holdings, Inc. Common Stock shares in Q3 2022, an estimated $239K.
  • Alyeska Investment Group first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Alyeska Investment Group's Surgalign Holdings, Inc. Common Stock position peaked at $639K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2022.

Based on Alyeska Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.